Laurus Labs signs MOA with IIT Kanpur for novel gene therapy assets

Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets

Lantern Pharma leverages AI platform to develop breakthrough ADCs with Bielefeld University

Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration

Oncodesign Services and Veritas In Silico jointly to develop mRNA-targeted small molecule drugs

The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets

Sai Life Sciences opens research facility SSRL

Fully equipped labs with 75-member team set-up and made operational in <100 days

NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate

Study efficacy measures will include the expression of dystrophin protein and motor function.

CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells

CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells

CAHO and Dozee join hands to discuss emerging role of AI in healthcare

70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai

Mindset Pharma to defend against lawsuit filed by Reunion Neurosciences

Mindset disagrees with and denies the allegations set forth from Reunion.

Dalton ramp ups sterile manufacturing capacity

The new sterile filling line meets cGMP aseptic filling regulatory requirements

Johnson & Johnson appoints Dr. John Reed as EVP, Pharmaceuticals, R&D